| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587466 | Diabetes Research and Clinical Practice | 2016 | 23 Pages |
Abstract
Teneligliptin may contribute toward reducing the total daily insulin dose and preventing hypoglycemic events on the hemodialysis day in type 2 diabetes mellitus patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Takahiro Yajima, Kumiko Yajima, Makoto Hayashi, Hiroshi Takahashi, Keigo Yasuda,